Genetic engineering biologicals in the treatment of AA-amyloidosisin patients with rheumatoid arthritis

Genetic engineering biologicals in the treatment of AA-amyloidosisin patients with rheumatoid arthritis

Bibliographic Details
Main Author:	Yuri Vladimirovich Muravyev
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2010-04-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1258

Similar Items

Methotrexate dosage in the treatment of rheumatoid arthritis
by: Yuri Vladimirovich Muravyev
Published: (2013-11-01)

ON CRITERIA FOR THE EFFICIENCY OF TREATMENT FOR RHEUMATOID ARTHRITIS
by: Yuri Vladimirovich Muravyev
Published: (2012-12-01)

How is folic acid to be used in rheumatoid arthritis during methotrexate treatment?
by: Yuri Vladimirovich Muravyev
Published: (2013-04-01)

Significance of SAA1 gene polymorphism in the development of AA amyloidosis in patients with rheumatoid arthritis in the Moscow population
by: V A Myakotkin, et al.
Published: (2012-08-01)

Lung lesion caused by the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
by: Yuriy Vladimirovich Murav'ev, et al.
Published: (2010-12-01)

Evolution of ideas on drug-induced tuberculosis in rheumatoid arthritis
by: Yuri Vladimirovich Muravyev, et al.
Published: (2010-04-01)

Current practice of methotrexate treatment for rheumatoid arthritis
by: Yuri Vladimirovich Muravyev, et al.
Published: (2012-08-01)

Etanercept In the treatment of AA-amyloidosis in juvenile rheumatoid arthritis
by: H Mihels
Published: (2004-08-01)

USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: E L Nasonov, et al.
Published: (2010-03-01)

USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: E L Nasonov, et al.
Published: (2010-03-01)

Safety of using genetic engineering biological agents in rheumatoid arthritis
by: N V Chichasova, et al.
Published: (2010-03-01)

EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2018-07-01)

USE OF GENETICALLY ENGINEERED BIOLOGICAL DRUGS FOR RHEUMATOID ARTHRITIS IN THE RUSSIAN FEDERATION
by: Rimma Mikhailovna Balabanova, et al.
Published: (2012-12-01)

Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
by: Irina Mikhailovna Marusenko
Published: (2013-12-01)

Unusual course of AA amiloidosis in a patient with rheumatoid arthritis
by: Y V Muravjev, et al.
Published: (2009-04-01)

The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis
by: Yu. V. Muravyev, et al.
Published: (2018-09-01)

Use of genetically engineered biological agents for the treatment of rheumatoid arthritis: general characteristics (a lecture)
by: Evgeni Lvovich Nasonov, et al.
Published: (2013-04-01)

Discussion questions of national classification of rheumatoid arthritis
by: Y. V. Muravyev
Published: (2007-04-01)

NEW POSSIBILITIES FOR MONITORING METHOTREXATE EFFICACY IN RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2015-09-01)

Rheumatoid arthritis classification criteria: debatable problems
by: Yu. V. Muravyev, et al.
Published: (2019-01-01)

Biologic monotherapy in the treatment of rheumatoid arthritis
by: Detert J, et al.
Published: (2015-05-01)

Experience with abatacept used in the treatment of patients with rheumatoid arthritis
by: V I Mazurov, et al.
Published: (2011-12-01)

Possible reasons for the inefficacy of genetically engineered biological agents in rheumatoid arthritis and ways of its prevention
by: Natalia Vladimirovna Chichasova
Published: (2012-06-01)

WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?
by: Yu. V. Muravyev, et al.
Published: (2017-03-01)

Effect of biological treatment on the daily functioning of patients with rheumatoid arthritis
by: Miriam Miedziak, et al.
Published: (2017-08-01)

Effect of biological treatment on the daily functioning of patients with rheumatoid arthritis
by: Miriam Miedziak, et al.
Published: (2017-08-01)

Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy
by: Jennifer L Barton
Published: (2009-11-01)

Role of biological agents in treatment of rheumatoid arthritis
by: Law, S, et al.
Published: (2019)

Initial Treatment with Biological Therapy in Rheumatoid Arthritis
by: Jesús Tornero Molina, et al.
Published: (2023-12-01)

Biological agents in monotherapy for the treatment of rheumatoid arthritis
by: Cem Gabay, et al.
Published: (2014-04-01)

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. I. Gridneva, et al.
Published: (2017-03-01)

Rheumatoid arthritis genetics
by: M A Moshnina
Published: (2005-08-01)

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
by: Krzysztof Bonek, et al.
Published: (2021-02-01)

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
by: Victoria Furer, et al.
Published: (2023-04-01)

SAFETY OF USING METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2015-09-01)

Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
by: Mahlich J, et al.
Published: (2016-08-01)

Biologic therapy of rheumatoid arthritis
by: Damjanov Nemanja, et al.
Published: (2009-01-01)

Trends in the idea of the safety of glucocorticoids in rheumatoid arthritis
by: Yu V Murav'ev, et al.
Published: (2011-04-01)

Safety and efficiency of therapy by gene-engineering-biological preparations of rheumatoid arthritis
by: E. A. Strel’tsov
Published: (2018-10-01)

IMPACT OF BIOLOGICAL THERAPY ON BONE IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: P. S. Dydykina, et al.
Published: (2014-12-01)